Cargando…

Prophylactic Low-dose Heparin or Prostaglandin E(1) may Prevent Severe Veno-occlusive Disease of the Liver after Allogeneic Hematopoietic Stem Cell Transplantation in Korean Children

Studies investigating the effect of prophylactic drugs on hepatic veno-occlusive disease (VOD) development are rare in children that have undergone allogeneic hematopoietic stem cell transplantation (HSCT). This study examined risk factors for VOD, the effect of prophylactic low-dose heparin or lipo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Joon Sup, Seo, Jong Jin, Moon, Hyung Nam, Ghim, Thad, Im, Ho Joon
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2006
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722002/ https://www.ncbi.nlm.nih.gov/pubmed/17043426 http://dx.doi.org/10.3346/jkms.2006.21.5.897

Ejemplares similares

Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin
por: Stutz, Lina, et al.
Publicado: (2022)

Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation
por: Shin, Seung-Hwan, et al.
Publicado: (2013)

Improved outcome in childhood ALL with intensive consolidation and hematopoietic stem cell transplant
por: Park, Jeong A, et al.
Publicado: (2010)

Hepatic veno-occlusive disease may develop in secondary iron overloaded mice after allogeneic hematopoietic stem cell transplantation with total body irradiation
por: Yeom, Mi Young, et al.
Publicado: (2015)

Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
por: Schneider, Veronika, et al.
Publicado: (2023)

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study
por: Forrest, D L, et al.
Publicado: (2003)

Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases
por: Park, Meerim, et al.
Publicado: (2011)

Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children
por: Bae, Keun Wook, et al.
Publicado: (2012)

Early central nervous system complications after allogeneic hematopoietic stem cell transplantation in children
por: Koh, Kyung Nam, et al.
Publicado: (2010)

Defibrotide for hepatic veno-occlusive disease
Publicado: (2021)

Influence of creatinine levels on survival in patients with veno-occlusive disease treated with defibrotide
por: Kong, Seom Gim, et al.
Publicado: (2022)

Pulmonary Veno-occlusive Disease that Developed Following Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
por: Takeda, Kenichiro, et al.
Publicado: (2022)

Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R ‐Related Leukoencephalopathy
por: Horn, Morten Andreas, et al.
Publicado: (2022)

Unrelated Hematopoietic Stem Cell Transplantation for Children with Acute Leukemia: Experience at a Single Institution
por: Lee, Jae Hee, et al.
Publicado: (2009)

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
por: Lee, J. H., et al.
Publicado: (1996)

Defibrotide in the treatment of hepatic veno-occlusive disease
por: Fulgenzi, Alessandro, et al.
Publicado: (2016)

Mitomycin induced pulmonary veno-occlusive disease
por: Kunadu, Afua, et al.
Publicado: (2021)

Genetic cause of pulmonary veno-occlusive disease
por: Mohite, Kaustubh, et al.
Publicado: (2022)

Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study
por: Putta, Santosh, et al.
Publicado: (2023)

213. Prophylactic oral vancomycin for Clostridioides difficile in allogeneic hematopoietic stem cell transplant recipients
por: Ogawa, Lauren, et al.
Publicado: (2022)

Hepatic sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea
por: Yoon, Jae-Ho, et al.
Publicado: (2021)

Interprofessional Team-based Care of the Hematopoietic Cell Transplantation Patient With Hepatic Veno-occlusive Disease/Sinusoidal Obstruction Syndrome
por: Mangada, Kristin L., et al.
Publicado: (2023)

Pulmonary veno‐occlusive disease with vanished pulmonary consolidation
por: Yamasaki, Kei, et al.
Publicado: (2023)

Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
por: Gaffney, Kelly J., et al.
Publicado: (2023)

Subcutaneous hematomas from prophylactic heparin use
por: Koratala, Abhilash, et al.
Publicado: (2017)

Pulmonary veno-occlusive disease after respiratory syncytial virus infection in a post hematopoietic stem cell transplantation patient
por: Watanabe, Tatsuo, et al.
Publicado: (2023)

Time to establish multidisciplinary childhood cancer survivorship programs in Korea
por: Ghim, Thad T.
Publicado: (2010)

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group
por: Mohty, Mohamad, et al.
Publicado: (2019)

Two difficulty diagnosis cases of severe veno-occlusive disease
por: Miyaaki, Hisamitsu, et al.
Publicado: (2013)

A case of veno-occlusive disease following liver transplantation
por: CHEN, HONG, et al.
Publicado: (2014)

The importance of early intervention in the treatment of hepatic veno-occlusive disease
por: Pagliuca, Antonio
Publicado: (2019)

Anti-synthetase syndrome-associated pulmonary veno-occlusive disease
por: Kay, Diana, et al.
Publicado: (2020)

Successful surgical management of mesenteric inflammatory veno-occlusive disease
por: Matsuda, Keiji, et al.
Publicado: (2020)

Progression of pulmonary veno‐occlusive disease without pulmonary hypertension
por: Beshay, Sarah, et al.
Publicado: (2022)

Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease
por: Mavrikou, Ioulia, et al.
Publicado: (2023)

An isolated cardiac relapse after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia
por: Chang, Kiju, et al.
Publicado: (2017)

Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients
por: Corbacioglu, Selim, et al.
Publicado: (2020)

Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome
por: Lai, Xiaoxuan, et al.
Publicado: (2021)

Normalization of Red Cell Enolase Level Following Allogeneic Bone Marrow Transplantation in a Child with Diamond-Blackfan Anemia
por: Park, Jeong A, et al.
Publicado: (2010)

Hepatic veno-occlusive disease may be a rare characteristic of hepatic involvement in systemic amyloidosis: case report and literature review
por: Zhu, Tong-Yin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jsn7bp2j43ul4246ecc588tmlb